Sep 06, 2023 / 12:45PM GMT
Stephen C. Baxter - Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
Hi, everyone. I'm Steve Baxter, the healthcare services analyst. Thanks for coming to the Wells Fargo conference this year. We're pleased to be joined by Centene, a leading health plan focused on government-sponsored coverage, most notably Medicaid. In the company, we have Sarah London, CEO; Drew Asher, CFO; and Jennifer Gilligan from Investor Relations. Thank you for being here today. Before we launch into my questions, Sarah, Drew, do you have any opening remarks you wanted to start.
Sarah M. London - Centene Corporation - CEO & Director
Yes. Maybe I can just give a quick update on what we've been up to since our Q2 call. We started the quarter with a good July. And then in August, we purchased another $200 million worth of shares in the 60s, and we expect to exceed our original $1.5 billion share repurchase target in 2023.
And then just a couple of weeks ago, I'm sure many of you saw that we hit a major milestone in our value creation plan and portfolio
Centene Corp at Wells Fargo Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot